Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients.
about
Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insightsBiomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapyCirculating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring.Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy.Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy.Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis.The status of transarterial chemoembolization treatment in the era of precision oncology.Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
P2860
Q26799928-460EADDE-A093-40EA-B13A-C8D2BB7DC81AQ34256150-D9369C41-EE3F-471E-BAC2-C68682C19005Q37534945-E86D2EAC-67D7-41E0-A048-580B16D219E8Q38012465-A0A4BED3-0994-4EC7-B331-198E4F31DCE5Q44357744-3EAC7F89-C0AD-42D1-AA1B-1ABAAA0628FAQ44844478-6484D5ED-2DDF-4EC4-8879-231E41F812EEQ49332660-81DEAC10-746D-41DF-B5F2-72CF327A6F4AQ49491370-BEF8E829-E480-4C58-B77D-618250AF8765Q50943644-D3960571-F0C3-48F7-B463-A8DE781DB227Q53271003-A53DF68C-323A-41B3-BC8F-3315CFFCB5B5
P2860
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Relevance of circulating nucle ...... rapy in liver cancer patients.
@ast
Relevance of circulating nucle ...... rapy in liver cancer patients.
@en
type
label
Relevance of circulating nucle ...... rapy in liver cancer patients.
@ast
Relevance of circulating nucle ...... rapy in liver cancer patients.
@en
prefLabel
Relevance of circulating nucle ...... rapy in liver cancer patients.
@ast
Relevance of circulating nucle ...... rapy in liver cancer patients.
@en
P2093
P2860
P356
P1433
P1476
Relevance of circulating nucle ...... rapy in liver cancer patients.
@en
P2093
Dietrich Jüngst
Dorothea Nagel
Jürgen Durner
Nikolaus Kohles
Petra Stieber
Stefan Holdenrieder
P2860
P2888
P356
10.1186/1471-2407-11-202
P407
P577
2011-05-26T00:00:00Z
P5875
P6179
1045973900